She advises doctors to be proactive in monitoring the risk in GLP-1 patients, especially in postmenopausal women and men over age 50 who would already be at higher risk of bone loss due to their age
But the good news is that youre not alone and there are effective solutions out there
Indeed, in subsequent studies with infusions of physiological amounts of GLP-1 both its insulinotropic and its glucagon-inhibitory effects (at fasting glucose concentrations!) as well as an ensuing reduction of hepatic glucose production were demonstrated in human volunteers (63)
5a, the pretreatment with Src inhibitor (SKI-1) significantly reduced the effect of BPC 157 on the phosphorylation of Src, Cav-1 and eNOS, further confirming the critical upstream role of Src in this pathway
PlexusDx partners with licensed 503A compounding pharmacies to deliver affordable, personalized options ranging from $129/mo to $349/mo per month
But perhaps its a judgment call, and theres flexibility